2008 has seen no decrease in the opportunities available for outsourcing drug discovery, for a number of reasons. New technologies increase the number of targets and accelerate the identification of active compounds. There is increasing pressure to develop new lead compounds due to the near-term loss of patent protection for many drug product. And there is also pressure to reduce the time spent in drug discovery and to bring drugs to market sooner, as well as the ever-present cost considerations. Kalorama Information's Outsourcing in Drug Discovery offers unparalleled discussion of the drug discovery outsourcing market. It presents viewpoints from both customers and suppliers. Segments, size, and growth of the market are presented. The trend toward the increased use of offshore suppliers is covered in detail. The report also provides profiles of 23 suppliers, representative of those active in this market. Segments covered in this report include:
In addition to market data and forecasts, the report covers issues such as:
This report looks offshore at outsourcing suppliers based in three major areas: India, China, and Eastern Europe. The relative advantages each country provides are contrasted with some of their limitations. The report asses which projects are moving to which suppliers and why. Related Reports: Vaccines 2010: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing IndustryAug 1, 2010 - KLI2684026 - $3,995.00 World Pharmaceutical and Biopharmaceutical Market, 2010-2015 (Pipeline Analysis of the Top 50 Companies) Jul 1, 2010 - KLI2691449 - $4,500.00 Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 4th Edition Jun 1, 2010 - KLI2605176 - $3,995.00 The Worldwide Over-the-Counter (OTC) Drug Market May 1, 2010 - KLI2661910 - $3,995.00 The Global Market for RFID in Healthcare May 1, 2010 - KLI2644911 - $3,995.00 H1N1 "Swine Flu" Vaccine Market Review (Revenues, Forecasts, Lessons for Future Pandemic Vaccines) May 1, 2010 - KLI2651343 - $1,200.00 The World Anesthesia Drug Market Apr 1, 2010 - KLI2614802 - $3,995.00 The Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals) Oct 1, 2009 - KLI2435380 - $3,500.00 The World Market for Biosimilars and the Potential for US Follow-on Biologics Aug 1, 2009 - KLI2402283 - $3,700.00 Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry Jun 1, 2009 - KLI2155319 - $3,995.00 |
800.298.5603
Int'l: +1.240.747.3096
Questions?
Contact a research specialist >
Most Popular Research
World Veterinary Health Products (Animal Pharmaceuticals, Vaccines, OTC and Performance Enhancers)
Clinical Nutrition Products: World Markets, 3rd Edition
What's Next in Vaccines? HIV, Malaria, MRSA, and 30 Other Vaccine Targets in the 2010-2016 Pipeline
The Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)
Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
Pharmaceutical Outsourcing Post-Launch : Contract Manufacturing, Biomanufacturing and Sales, 3rd Edition
|
|||||||||
|
Privacy Policy
|
Terms and Conditions
|
Site Map
|
Return Policy
|
Press
|
Help FAQs
|